Sensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking-induced conversion

Journal of General Virology

Volumn 93, Issue 2, 2012, Pages

  Peden, Alexander H ^a   McGuire, Lynne I ^a   Appleford, Nigel E J ^b   Mallinson, Gary ^b   Wilham, Jason M ^c   Orrú, Christina D ^c   Caughey, Byron ^c   Ironside, James W ^a   Knight, Richard S ^a   Will, Robert G ^a   Green, Alison J E ^a   Head, Mark W ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHIONINE; PRION PROTEIN; VALINE; AMYLOID;

ARTICLE; CODON; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; GENE SEQUENCE; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; REAL TIME QUAKING INDUCED CONVERSION; SENSITIVITY AND SPECIFICITY; ANIMAL; BRAIN; COMPARATIVE STUDY; HAMSTER; METHODOLOGY; PATHOLOGY; PRION; PROTEIN CONFORMATION; PROTEIN FOLDING; TIME;

CRICETINAE; OVIS ARIES; RODENTIA;

AMYLOID; ANIMALS; BRAIN; CREUTZFELDT-JAKOB SYNDROME; CRICETINAE; HUMANS; PATHOLOGY; PRIONS; PROTEIN CONFORMATION; PROTEIN FOLDING; TIME FACTORS;

EID: 84855913114     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.033365-0     Document Type: Article

References (36)

1. Atarashi, R., Moore, R. A., Sim, V. L., Hughson, A. G., Dorward, D. W., Onwubiko, H. A., Priola, S. A. & Caughey, B. (2007). Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat Methods 4, 645-650.
2. Atarashi, R., Wilham, J. M., Christensen, L., Hughson, A. G., Moore, R. A., Johnson, L. M., Onwubiko, H. A., Priola, S. A. & Caughey, B. (2008). Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat Methods 5, 211-212.
3. Atarashi, R., Satoh, K., Sano, K., Fuse, T., Yamaguchi, N., Ishibashi, D., Matsubara, T., Nakagaki, T., Yamanaka, H. & other authors (2011). Ultrasensitive human prion detection in cerebrospinal fluid by realtime quaking-induced conversion. Nat Med 17, 175-178.
4. Bishop, M. T., Will, R. G. & Manson, J. C. (2010). Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. Proc Natl Acad Sci U S A 107, 12005-12010.
5. Brown, P., Brandel, J. P., Preece, M. & Sato, T. (2006). Iatrogenic Creutzfeldt-Jakob disease: the waning of an era. Neurology 67, 389-393.
6. Caughey, B., Baron, G. S., Chesebro, B. & Jeffrey, M. (2009). Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annu Rev Biochem 78, 177-204.
7. Chia, R., Tattum, M. H., Jones, S., Collinge, J., Fisher, E. M. & Jackson, G. S. (2010). Superoxide dismutase 1 and tgSOD1 mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosis. PLoS ONE 5, e10627.
8. Choi, Y. P., Gröner, A., Ironside, J. W. & Head, M. W. (2011). Comparison of the level, distribution and form of disease-associated prion protein in variant and sporadic Creutzfeldt-Jakob diseased brain using conformation-dependent immunoassay and Western blot. J Gen Virol 92, 727-732.
9. Colby, D. W., Zhang, Q., Wang, S., Groth, D., Legname, G., Riesner, D. & Prusiner, S. B. (2007). Prion detection by an amyloid seeding assay. Proc Natl Acad Sci U S A 104, 20914-20919.
10. Gambetti, P., Kong, Q., Zou, W., Parchi, P. & Chen, S. G. (2003). Sporadic and familial CJD: classification and characterisation. Br Med Bull 66, 213-239.
11. Hewitt, P. E., Llewelyn, C. A., Mackenzie, J. & Will, R. G. (2006). Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang 91, 221-230.
12. Hilton, D. A. (2006). Pathogenesis and prevalence of variant Creutzfeldt-Jakob disease. J Pathol 208, 134-141.
13. Ironside, J. W., Ghetti, B., Head, M. W., Piccardo, P. & Will, R. G. (2008). Prion diseases. In Greenfield's Neuropathology, Vol. 2. 8th edn, pp. 1197-1273. Edited by S. Love, D. N. Louis & D. W. Ellison. London: Hodder and Arnold.
14. Jones, M., Peden, A. H., Prowse, C. V., Gröner, A., Manson, J. C., Turner, M. L., Ironside, J. W., MacGregor, I. R. & Head, M. W. (2007). In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc. J Pathol 213, 21-26.
15. Jones, M., Peden, A. H., Wight, D., Prowse, C., Macgregor, I., Manson, J., Turner, M., Ironside, J. W. & Head, M.W. (2008). Effects of human PrPSc type and PRNP genotype in an in-vitro conversion assay. Neuroreport 19, 1783-1786.
16. Jones, M., Peden, A. H., Yull, H., Wight, D., Bishop, M. T., Prowse, C. V., Turner, M. L., Ironside, J. W., MacGregor, I. R. & Head, M. W. (2009a). Human platelets as a substrate source for the in vitro amplification of the abnormal prion protein (PrP) associated with variant Creutzfeldt-Jakob disease. Transfusion 49, 376-384.
17. Jones, M., Wight, D., Barron, R., Jeffrey, M., Manson, J., Prowse, C., Ironside, J. W. & Head, M. W. (2009b). Molecular model of prion transmission to humans. Emerg Infect Dis 15, 2013-2016.
18. Jones, M., Peden, A. H., Head, M. W. & Ironside, J. W. (2011). The application of in vitro cell-free conversion systems to human prion diseases. Acta Neuropathol 121, 135-143.
19. Llewelyn, C. A., Hewitt, P. E., Knight, R. S., Amar, K., Cousens, S., Mackenzie, J. & Will, R. G. (2004). Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363, 417-421.
20. Nielsen, L., Frokjaer, S., Brange, J., Uversky, V. N. & Fink, A. L. (2001). Probing the mechanism of insulin fibril formation with insulin mutants. Biochemistry 40, 8397-8409.
21. Orrú, C. D., Wilham, J. M., Hughson, A. G., Raymond, L. D., McNally, K. L., Bossers, A., Ligios, C. & Caughey, B. (2009). Human variant Creutzfeldt-Jakob disease and sheep scrapie PrPres detection using seeded conversion of recombinant prion protein. Protein Eng Des Sel 22, 515-521.
22. Orrú, C. D., Wilham, J. M., Raymond, L. D., Kuhn, F., Schroeder, B., Raeber, A. J. & Caughey, B. (2011). Prion disease blood test using immunoprecipitation and improved quaking-induced conversion. MBio 2, e00078-11.
23. Parchi, P., Giese, A., Capellari, S., Brown, P., Schulz-Schaeffer, W., Windl, O., Zerr, I., Budka, H., Kopp, N. & other authors (1999). Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46, 224-233.
24. Parchi, P., Cescatti, M., Notari, S., Schulz-Schaeffer, W. J., Capellari, S., Giese, A., Zou, W. Q., Kretzschmar, H., Ghetti, B. & Brown, P. (2010). Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease. Brain 133, 3030-3042.
25. Peden, A. H., Head, M. W., Ritchie, D. L., Bell, J. E. & Ironside, J. W. (2004). Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364, 527-529.
26. Peden, A. H., Head, M. W., Jones, M., MacGregor, I. R., Turner, M. L. & Ironside, J. W. (2008). Advances in the development of a screening test for variant Creutzfeldt-Jakob disease. Expert Opin Med Diagn 2, 207-219.
27. Peden, A., McCardle, L., Head, M. W., Love, S., Ward, H. J., Cousens, S. N., Keeling, D. M., Millar, C. M., Hill, F. G. & Ironside, J. W. (2010). Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia 16, 296-304.
28. Prusiner, S. B. (1998). Prions. Proc Natl Acad Sci U S A 95, 13363-13383.
29. Safar, J., Wille, H., Itri, V., Groth, D., Serban, H., Torchia, M., Cohen, F. E. & Prusiner, S. B. (1998). Eight prion strains have PrPSc molecules with different conformations. Nat Med 4, 1157-1165.
30. Safar, J. G., Geschwind, M. D., Deering, C., Didorenko, S., Sattavat, M., Sanchez, H., Serban, A., Vey, M., Baron, H. & other authors (2005). Diagnosis of human prion disease. Proc Natl Acad Sci U S A 102, 3501-3506.
31. Silveira, J. R., Raymond, G. J., Hughson, A. G., Race, R. E., Sim, V. L., Hayes, S. F. & Caughey, B. (2005). The most infectious prion protein particles. Nature 437, 257-261.
32. Turner, M. L. & Ludlam, C. A. (2009). An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products. Br J Haematol 144, 14-23.
33. Wilham, J.M., Orrú, C. D., Bessen, R. A., Atarashi, R., Sano, K., Race, B., Meade-White, K. D., Taubner, L. M., Timmes, A. & Caughey, B. (2010). Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathog 6, e1001217.
34. Will, B. (2010). Variant CJD: where has it gone, or has it? Pract Neurol 10, 250-251.
35. Wroe, S. J., Pal, S., Siddique, D., Hyare, H., Macfarlane, R., Joiner, S., Linehan, J. M., Brandner, S., Wadsworth, J. D. & other authors (2006). Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 368, 2061-2067.
36. Yull, H. M., Ritchie, D. L., Langeveld, J. P., van Zijderveld, F. G., Bruce, M. E., Ironside, J. W. & Head, M. W. (2006). Detection of type 1 prion protein in variant Creutzfeldt-Jakob disease. Am J Pathol 168, 151-157.